Literature DB >> 20499029

Serous cystadenocarcinoma of the pancreas with portal thrombosis.

S Vadalà1, G Calderera, N Cinardi, M Manusia, G Li Volti, G Giannone.   

Abstract

Serous cystadenocarcinoma of the pancreas is a rare entity. We report on a primary tumor of the pancreas in a 74-year-old male. Computerized tomography showed an abdominal mass within pancreatic head, portal vein infiltration and absence of metastatic lesions. Patient underwent Whipple's procedure and portal vein thrombectomy. Pathologic examinations of the specimen showed it to be serous cystadenocarcinoma. To the knowledge of the authors, serous cystic neoplasms of the pancreas have been uniformly benign in biologic behaviour. However, serous cystadenocarcinoma of the pancreas has been reported as a new entity. The current report is the fi rst among 22 cases described to present portal vein thrombosis and might support the local malignant behaviour of this controversial class of tumours.

Entities:  

Mesh:

Year:  2010        PMID: 20499029

Source DB:  PubMed          Journal:  Clin Ter        ISSN: 0009-9074


  4 in total

1.  Imaging of pancreatic serous cystadenocarcinoma.

Authors:  Shahina Bano; Lalendra Upreti; Sunil Kumar Puri; Vikas Chaudhary; Puja Sakuja
Journal:  Jpn J Radiol       Date:  2011-10-19       Impact factor: 2.374

2.  Histological percutaneous diagnosis of stage IV microcystic serous cystadenocarcinoma of the pancreas.

Authors:  Bassam Abu Wasel; Valerie Keough; Weei-Yuan Huang; Michele Molinari
Journal:  BMJ Case Rep       Date:  2013-01-30

3.  Case Report: Pancreatic Neuroendocrine Tumor With Liver Metastasis and Portal Vein Thrombosis.

Authors:  Yulong Tian; Xingshun Qi; Afaf Aljbri; Ke Xu; Hongshan Zhong
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 6.244

Review 4.  Malignant pancreatic serous cystic neoplasms: systematic review with a new case.

Authors:  Jimi Huh; Jae Ho Byun; Seung-Mo Hong; Kyung Won Kim; Jin Hee Kim; Seung Soo Lee; Hyoung Jung Kim; Moon-Gyu Lee
Journal:  BMC Gastroenterol       Date:  2016-08-22       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.